Monsanto May Receive Compensation for Roundup Ready Plants in Argentina/ Screening Method Patent Finally Revoked/ Nucleonics Requests Reexamination of Gene Expression Patent/ Oncomouse Patent Maintained in Amended Form/ Impax Drug for ALS Infringes Aventis Patent/ NIH Declines to March in on AIDS Drug/ Genzyme Agrees to Royalties on Noncoding DNA/ Mammalian Cloning Patent Issues/ New Practice Rules, Fee Schedule from

Abstract

Biotechnology Law ReportVol. 23, No. 6 PatentsMonsanto May Receive Compensation for Roundup Ready Plants in Argentina/ Screening Method Patent Finally Revoked/ Nucleonics Requests Reexamination of Gene Expression Patent/ Oncomouse Patent Maintained in Amended Form/ Impax Drug for ALS Infringes Aventis Patent/ NIH Declines to March in on AIDS Drug/ Genzyme Agrees to Royalties on Noncoding DNA/ Mammalian Cloning Patent Issues/ New Practice Rules, Fee Schedule from PTOPublished Online:28 Dec 2004https://doi.org/10.1089/blr.2004.23.754AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetails Volume 23Issue 6Dec 2004 InformationCopyright 2004, Mary Ann Liebert, Inc.To cite this article:Monsanto May Receive Compensation for Roundup Ready Plants in Argentina/ Screening Method Patent Finally Revoked/ Nucleonics Requests Reexamination of Gene Expression Patent/ Oncomouse Patent Maintained in Amended Form/ Impax Drug for ALS Infringes Aventis Patent/ NIH Declines to March in on AIDS Drug/ Genzyme Agrees to Royalties on Noncoding DNA/ Mammalian Cloning Patent Issues/ New Practice Rules, Fee Schedule from PTO.Biotechnology Law Report.Dec 2004.754-757.http://doi.org/10.1089/blr.2004.23.754Published in Volume: 23 Issue 6: December 28, 2004PDF download